Avantor® to Participate in the 41st Annual J.P. Morgan Healthcare Conference
Avantor, Inc. (NYSE: AVTR) has announced that Michael Stubblefield, President and CEO, will present at the 41st Annual J.P.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Avantor, Inc. (NYSE: AVTR) has announced that Michael Stubblefield, President and CEO, will present at the 41st Annual J.P. Morgan Healthcare Conference on January 9, 2023, at 12:45 p.m. EST. The presentation can be accessed via a live audio webcast by visiting the Events & Presentations section on Avantor's website. A replay will be available for 30 days after the event. Avantor provides essential products and services for life sciences and advanced technologies across over 180 countries, serving more than 225,000 customer locations.
Details
News Market Reaction – AVTR
The recorded move for AVTR in the trading session of this news was +0.38%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
RADNOR, Pa., Jan. 3, 2023 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences, advanced technologies and applied materials industries, announced that Michael Stubblefield, President and CEO, will present at the 41st Annual J.P. Morgan Healthcare Conference on Monday, January 9, at approximately 12:45 p.m. Eastern Standard Time.
To hear a live audio webcast of the presentation, visit the "Events & Presentations" page of Avantor's website, www.avantorsciences.com, under the "Investors" section. A replay of the webcast will be available for 30 days.
Avantor®, a Fortune 500 company, is a leading global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. Our portfolio is used in virtually every stage of the most important research, development and production activities in the industries we serve. Our global footprint enables us to serve more than 225,000 customer locations and gives us extensive access to research laboratories and scientists in more than 180 countries. We set science in motion to create a better world. For more information, visit avantorsciences.com and find us on LinkedIn, Twitter and Facebook.
Investor Relations Contact
Christina Jones
Vice President, Investor Relations
Avantor
805-617-5297
Christina.Jones@avantorsciences.com
Global Media Contact
Petro Kacur
Director, PR and External Communications
Avantor
404-408-0663
Petro.Kacur@avantorsciences.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/avantor-to-participate-in-the-41st-annual-jp-morgan-healthcare-conference-301712047.html
SOURCE Avantor and Financial News
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.